ID   KM3900
AC   CVCL_D3PS
DR   ABCD; ABCD_AI949
RX   Patent=US8076458;
RX   PubMed=19555390;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10751.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   Patent=US8076458;
RA   Ohta S., Ando H., Suzuki M., Kawamoto S., Kato-Nakano M., Nakamura K.;
RT   "Anti-claudin-4 antibody.";
RL   Patent number US8076458, 13-Dec-2011.
//
RX   PubMed=19555390; DOI=10.1111/j.1349-7006.2009.01239.x;
RA   Suzuki M., Kato-Nakano M., Kawamoto S., Furuya A., Abe Y., Misaka H.,
RA   Kimoto N., Nakamura K., Ohta S., Ando H.;
RT   "Therapeutic antitumor efficacy of monoclonal antibody against
RT   claudin-4 for pancreatic and ovarian cancers.";
RL   Cancer Sci. 100:1623-1630(2009).
//